Dermatitis atopic
Not recruitingStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
- Disease:Dermatitis atopic
- Substances:Rocatinlimab
Poland- Participants:18–64 years · 65+ years
- Substances:Rocatinlimab
- Sponsor:Amgen Inc.
Rare diseases
Investigational molecules
Locations
Back to Poland115 clinical trials in Tarnow, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on respiratory conditions including asthma management in both adults and children. Clinical trials are evaluating new treatments for respiratory syncytial virus (RSV) and chronic cough conditions.
Several trials are investigating novel inhalation therapies and biological treatments for severe asthma cases.
Comprehensive studies addressing cardiovascular diseases and heart failure. Research includes innovative combination therapies and treatments targeting specific cardiovascular risk factors.
Trials are exploring new approaches to prevent major cardiovascular events and improve patient outcomes.
Advanced research into Type 2 diabetes and obesity treatments. Studies are evaluating combination therapies and new compounds for weight management in diabetic patients.
Focus on developing integrated approaches for managing both diabetes and obesity simultaneously.
Tell us about your condition – we search every trial in Europe and connect you with the right site.